Emergency Medicine 201
-
Intro to Emergency Medicine6 Topics|2 Quizzes
-
Rapid Sequence Intubation8 Topics|2 Quizzes
-
Pre-Quiz: Rapid Sequence Intubation
-
Introduction: Rapid Sequence Intubation
-
Pretreatment drugs: Rapid Sequence Intubation
-
Induction Agents For Rapid Sequence Intubation
-
Paralytic Agents For Rapid Sequence Intubation
-
Literature Review: Rapid Sequence Intubation
-
Rapid Sequence Intubation Videos
-
Summary & References: Rapid Sequence Intubation
-
Pre-Quiz: Rapid Sequence Intubation
-
Cardiac Arrest Pharmacotherapy8 Topics|3 Quizzes
-
Pre-Quiz: Cardiac Arrest
-
Introduction and Background
-
Basic Life Support
-
ACLS Algorithm: Non shockable Rhythms (Asystole and Pulse Electric Activity or PEA)
-
ACLS Algorithm: Shockable Rhythms (Ventricular Fibrillation and Pulseless Ventricular Tachycardia)
-
Pharmacotherapy of Cardiac Arrest
-
Literature Review: Cardiac Arrest Pharmacotherapy
-
Summary and References
-
Pre-Quiz: Cardiac Arrest
-
Hyperglycemic Crisis: Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic Syndrome11 Topics|3 Quizzes
-
Pre-Quiz: Hyperglycemic Crisis: Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic Syndrome EM 201
-
Introduction
-
Clinical Presentation
-
Pathophysiology
-
Risk Factors and Precipitating Triggers
-
Diagnostic Approach
-
Fluid Resuscitation
-
Insulin Therapy
-
Hypoglycemia Management
-
Literature Review: Hyperglycemic Crisis
-
References
-
Pre-Quiz: Hyperglycemic Crisis: Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic Syndrome EM 201
-
Community-Acquired Pneumonia7 Topics|3 Quizzes
Quizzes
Participants 396
Pathophysiology and Clinical Manifestations
Pathophysiology
Inspiration of ambient air exposes the lungs to environmental and infectious particulate matter. These respiratory pathogens enter the lower respiratory tract by one of three routes:
- Direct inhalation of infectious droplets
- Aspiration of oropharyngeal contents
- Hematogenous spread from another infection site
Following inhalation, the pathogen colonizes the nasopharynx and then reaches the lung alveoli via microaspiration. When the inoculum size is sufficient and/or host immune defenses are impaired, infection results.
As in for immunocompromised patients, they lack robust defense mechanisms and therefore at a higher risk for immediate infection. Lung infections also suppress the antibacterial activity of the lungs by impairing alveolar macrophage function and mucociliary clearance, thus setting the stage for bacterial pneumonia.
Pneumonia arises when there is inflammation and damage of the lung parenchyma due to replication of the pathogen, production of virulence factors, and the host’s reduced immune response.
Clinical Manifestations
CAP has a wide spectrum of associated clinical features. It is for this reason that CAP is often part of the differential diagnosis of almost all respiratory illnesses. These presentations range from mild pneumonia characterized by fever, shortness of breath, and cough, to severe pneumonia with sepsis and respiratory distress. These symptoms are directly related to the immune response of the patient.